July 9, 2009 –Stentys said today it received CE mark approval for the European sale of its disconnectable and self-expanding stent platform for treatment of coronary artery bifurcations.
July 9, 2009 - Volcano Corporation said yesterday it signed a termination agreement with its largest distributor in Japan, Goodman Company Ltd., enabling Volcano to accelerate its transition to a direct sales force in the market to support its intravascular ultrasound (IVUS) and functional measurement (FM) consoles and disposables.
July 9. 2009 - Vascular Solutions, Inc. announces the availability of the new Trespass angiographic catheter specifically designed for use by interventional radiologists and other physicians performing endovascular Abdominal Aortic Aneurysm (AAA) repair procedures.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
July 9, 2009 - The U.S.
July 8, 2009 – Bioheart Inc. said this week a panel discussion on myoblast (muscle stem cell) therapy between distinguished physicians gave the technology a big endorsement.
July 8, 2009 - Pluristem Therapeutics Inc. said yesterday its first patient enrolled in a phase I clinical trial that will evaluate the safety of the company’s allogeneic, placental-derived, adherent stromal cell product, termed PLX-PAD. The product is for use in patients afflicted with critical limb ischemia (CLI), the end-stage of peripheral artery disease (PAD).
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
July 8, 2009 – CardioFocus Inc. said yesterday it received a CE mark in Europe for its Endoscopic Ablation System (EAS) to treat patients with atrial fibrillation.
July 8, 2009 - Marc Gerdisch, M.D., director of cardiothoracic surgery at the St. Francis Heart Center and a partner at Cardiac Surgery Associates, is using the CorMatrix Extracellular Matrix (ECM) to modify and repair cardiac structures, allowing heart tissue to regrow inside the beating hearts of heart surgery patients.
July 8, 2009 – A procedure that sends targeted energy into the heart through a catheter can be used to treat a common type of irregular heartbeat, but little is known about the treatment's long-term benefits and the best methods and circumstances for applying it, according to a new report funded by the Health and Human Services' (HHS’) Agency for Healthcare Research and Quality (AHRQ).
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
July 8, 2009 - Covidien said today Health Canada approved the company’s abbreviated new drug submission (ANDS) for its kit for the preparation of technetium Tc 99m Sestamibi injection. Covidien’s generic product is fully substitutable for Cardiolite, the company said.
July 8, 2009 - Ziosoft Inc., a leader in advanced visualization and analysis software for medical imaging, has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market its magnetic resonance (MR) cardiac function analysis application for use with the Ziostation thin-client system.
July 6, 2009 – Last week, Royal Philips Electronics released the Veradius X-ray system, a mobile C-arm with a super thin, flat detector.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
July 6, 2009 - ATS Medical Inc. today said the FDA cleared the first implant of the ATS Simulus Semirigid Annuloplasty Band, which was developed through the company’s collaboration with Genesee BioMedical and represents the latest addition to the expanding portfolio of valve repair products.
July 6, 2009 – Sanofi-aventis said last week the FDA approved its Multaq (dronedarone) 400 mg tablets for use in patients with atrial fibrillation (AF) or atrial flutter (AFL).
July 2, 2009 - The Centers for Medicare and Medicaid Services (CMS) today released its proposed 2010 Medicare physician fee schedule, which includes proposals to significantly cut payments for cardiovascular-related services, prompting a stern response from the American College of Cardiology (ACC). CMS projects the changes would reduce total Medicare payments to cardiology by 11 percent.